UniProt ID | SMAD7_HUMAN | |
---|---|---|
UniProt AC | O15105 | |
Protein Name | Mothers against decapentaplegic homolog 7 | |
Gene Name | SMAD7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 426 | |
Subcellular Localization | Nucleus . Cytoplasm . Interaction with NEDD4L or RNF111 induces translocation from the nucleus to the cytoplasm (PubMed:16601693). TGF-beta stimulates its translocation from the nucleus to the cytoplasm. PDPK1 inhibits its translocation from the nucl | |
Protein Description | Antagonist of signaling by TGF-beta (transforming growth factor) type 1 receptor superfamily members; has been shown to inhibit TGF-beta (Transforming growth factor) and activin signaling by associating with their receptors thus preventing SMAD2 access. Functions as an adapter to recruit SMURF2 to the TGF-beta receptor complex. Also acts by recruiting the PPP1R15A-PP1 complex to TGFBR1, which promotes its dephosphorylation. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.. | |
Protein Sequence | MFRTKRSALVRRLWRSRAPGGEDEEEGAGGGGGGGELRGEGATDSRAHGAGGGGPGRAGCCLGKAVRGAKGHHHPHPPAAGAGAAGGAEADLKALTHSVLKKLKERQLELLLQAVESRGGTRTACLLLPGRLDCRLGPGAPAGAQPAQPPSSYSLPLLLCKVFRWPDLRHSSEVKRLCCCESYGKINPELVCCNPHHLSRLCELESPPPPYSRYPMDFLKPTADCPDAVPSSAETGGTNYLAPGGLSDSQLLLEPGDRSHWCVVAYWEEKTRVGRLYCVQEPSLDIFYDLPQGNGFCLGQLNSDNKSQLVQKVRSKIGCGIQLTREVDGVWVYNRSSYPIFIKSATLDNPDSRTLLVHKVFPGFSIKAFDYEKAYSLQRPNDHEFMQQPWTGFTVQISFVKGWGQCYTRQFISSCPCWLEVIFNSR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
64 | Acetylation | RAGCCLGKAVRGAKG CCHHHHHHHHHCCCC | 30.66 | 12408818 | |
64 | Ubiquitination | RAGCCLGKAVRGAKG CCHHHHHHHHHCCCC | 30.66 | 12408818 | |
70 | Methylation | GKAVRGAKGHHHPHP HHHHHCCCCCCCCCC | 62.69 | 12408818 | |
70 | Acetylation | GKAVRGAKGHHHPHP HHHHHCCCCCCCCCC | 62.69 | 12408818 | |
70 | Ubiquitination | GKAVRGAKGHHHPHP HHHHHCCCCCCCCCC | 62.69 | 12408818 | |
96 | Phosphorylation | EADLKALTHSVLKKL HHHHHHHHHHHHHHH | 19.57 | 22817900 | |
101 | Ubiquitination | ALTHSVLKKLKERQL HHHHHHHHHHHHHHH | 54.63 | - | |
117 | Phosphorylation | LLLQAVESRGGTRTA HHHHHHHHCCCCEEE | 29.62 | - | |
121 | Phosphorylation | AVESRGGTRTACLLL HHHHCCCCEEEEEEE | 27.89 | - | |
206 | Phosphorylation | SRLCELESPPPPYSR HHHHHCCCCCCCCCC | 56.16 | - | |
249 | Phosphorylation | APGGLSDSQLLLEPG CCCCCCCCCEEECCC | 21.25 | - | |
354 | Phosphorylation | LDNPDSRTLLVHKVF CCCCCCCEEEEEEEC | 28.53 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
96 | T | Phosphorylation | Kinase | MELK | Q61846 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP2 | O00308 | PMID:21258410 |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF1 | Q9HCE7 | PMID:11278251 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF111 | Q6ZNA4 | PMID:14657019 |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF2 | Q9HAU4 | PMID:11163210 |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP1 | Q9H0M0 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:15946939 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
249 | S | Phosphorylation |
| 17327236 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SMAD7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
612229 | Colorectal cancer 3 (CRCS3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Control of Smad7 stability by competition between acetylation andubiquitination."; Gronroos E., Hellman U., Heldin C.H., Ericsson J.; Mol. Cell 10:483-493(2002). Cited for: INTERACTION WITH EP300, ACETYLATION AT LYS-64 AND LYS-70,UBIQUITINATION AT LYS-64 AND LYS-70, AND MUTAGENESIS OF LYS-64 ANDLYS-70. | |
Ubiquitylation | |
Reference | PubMed |
"Control of Smad7 stability by competition between acetylation andubiquitination."; Gronroos E., Hellman U., Heldin C.H., Ericsson J.; Mol. Cell 10:483-493(2002). Cited for: INTERACTION WITH EP300, ACETYLATION AT LYS-64 AND LYS-70,UBIQUITINATION AT LYS-64 AND LYS-70, AND MUTAGENESIS OF LYS-64 ANDLYS-70. |